Clinical evaluation of multiple sclerosis:: quantification by use of scales

被引:6
|
作者
Izquierdo, G [1 ]
Ruiz-Peña, JL [1 ]
机构
[1] Hop Univ Virgen Macarena, Serv Neurol, Unidad Esclerosis, E-41009 Seville, Spain
关键词
clinical evaluation; cognitive impairment; EDSS; fatigue; multiple sclerosis; functional composite; scales;
D O I
10.33588/rn.3602.2002350
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction. Clinical evaluation is indispensable in multiple sclerosis (MS)for the quantitative measurement of the extent of the disorder, which is in turn required to find out how the disease is evolving and the influence the different forms of treatment are having on it, both in the experimental phase and in the usual monitoring they are subjected to. Method We review the different scales that are used to evaluate the distinct symptomatic and functional aspects of MS and the repercussions these have on the extent of disability displayed in the patient's social and personal life. Although in recent years, the EDSS has been an essential, irreplaceable scale in MS, other instruments of measurement that complement it have also begun to appear. The fatigue, cognitive function and quality of life scales are being used more and more frequently. The Multiple Sclerosis Functional Composite is an instrument that is used more and more frequently in MS and has proved to be highly sensitive in the evaluation of very important clinical trials. Conclusions. The lack of correlation between the distinct scales corroborates the fact that they measure complementary aspects of MS.
引用
收藏
页码:145 / 152
页数:8
相关论文
共 50 条
  • [31] Clinical relevance of brain atrophy assessment in multiple sclerosis. Implications for its use in a clinical routine
    Zivadinov, Robert
    Jakimovski, Dejan
    Gandhi, Sirin
    Ahmed, Rahil
    Dwyer, Michael G.
    Horakova, Dana
    Weinstock-Guttman, Bianca
    Benedict, Ralph R. H.
    Vaneckova, Manuela
    Barnett, Michael
    Bergsland, Niels
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2016, 16 (07) : 777 - 793
  • [32] LIPOIC ACID AND MULTIPLE SCLEROSIS: A RANDOMIZED CONTROLLED CLINICAL TRIAL
    Khalili, Mohammad
    Eskandari, Ghazaleh
    Ghajarzadeh, Mahsa
    Azimi, Amirreza
    Eghtesadi, Shahryar
    Sahraian, Mohamad Ali
    Motevalian, Abbas
    Hashemi, Hasan
    Mirshafiey, Abbas
    Norouzi, Abbas
    CURRENT TOPICS IN NUTRACEUTICAL RESEARCH, 2012, 10 (02) : 95 - 99
  • [33] Evaluation of automated techniques for the quantification of grey matter atrophy in patients with multiple sclerosis
    Derakhshan, Mishkin
    Caramanos, Zografos
    Giacomini, Paul S.
    Narayanan, Sridar
    Maranzano, Josefina
    Francis, Simon J.
    Arnold, Douglas L.
    Collins, D. Louis
    NEUROIMAGE, 2010, 52 (04) : 1261 - 1267
  • [34] The Use of Focus Groups to Characterize Symptoms in Persons With Multiple Sclerosis
    Newland, Pamela K.
    Thomas, Florian P.
    Riley, Marguerite
    Flick, Louise H.
    Fearing, Arleen
    JOURNAL OF NEUROSCIENCE NURSING, 2012, 44 (06) : 351 - 357
  • [35] Gait quantification in multiple sclerosis: A single-centre experience of systematic evaluation
    Decavel, Pierre
    Sagawa, Yoshimasa, Jr.
    NEUROPHYSIOLOGIE CLINIQUE-CLINICAL NEUROPHYSIOLOGY, 2019, 49 (02): : 165 - 171
  • [36] Multiple sclerosis: emerging epidemiological trends and redefining the clinical course
    Portaccio, Emilio
    Magyari, Melinda
    Havrdova, Eva Kubala
    Ruet, Aurelie
    Brochet, Bruno
    Scalfari, Antonio
    Di Filippo, Massimiliano
    Tur, Carmen
    Montalban, Xavier
    Amatoa, Maria Pia
    LANCET REGIONAL HEALTH-EUROPE, 2024, 44
  • [37] Evaluation of machine learning-based classification of clinical impairment and prediction of clinical worsening in multiple sclerosis
    Noteboom, Samantha
    Seiler, Moritz
    Chien, Claudia
    Rane, Roshan P.
    Barkhof, Frederik
    Strijbis, Eva M. M.
    Paul, Friedemann
    Schoonheim, Menno M.
    Ritter, Kerstin
    JOURNAL OF NEUROLOGY, 2024, 271 (08) : 5577 - 5589
  • [38] The Multiple Sclerosis Functional Composite: a new clinical outcome measure for multiple sclerosis
    Rudick, RA
    Cutter, G
    Reinold, S
    MULTIPLE SCLEROSIS, 2002, 8 (05): : 359 - 365
  • [39] Quantification of Visual Fixation in Multiple Sclerosis
    Bijvank, Jenny A. Nij
    Petzold, Axel
    Coric, Danko
    Tan, H. Stevie
    Uitdehaag, Bernard M. J.
    Balk, Lisanne J.
    van Rijn, Laurentius J.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (05) : 1372 - 1383
  • [40] Hypnotic use and fatigue in multiple sclerosis
    Braley, Tiffany J.
    Segal, Benjamin M.
    Chervin, Ronald D.
    SLEEP MEDICINE, 2015, 16 (01) : 131 - 137